PUBLISHER: Inkwood Research | PRODUCT CODE: 1329852
PUBLISHER: Inkwood Research | PRODUCT CODE: 1329852
The China swabs collection kit market is predicted to project a CAGR of 2.48% during the forecast period, 2023-2030. Favorable regulatory framework and government initiatives boost growth aspects in China with regard to swabs collection kits.
The Chinese government has implemented various measures to bolster the manufacturing and supply of swab collection kits, with a focus on enhancing financial support and providing incentives. These actions involve streamlining regulatory processes, offering financial assistance to manufacturers, and promoting the growth of domestic manufacturing capacity to meet the escalating demand. According to the provincial budget report of Guangdong, the leading economic province in China, a total of $22 billion has been allocated for pandemic prevention and control efforts over the past three years, commencing in 2020.
China has emerged as a significant exporter of swab collection kits, catering to countries across the globe. The country's robust manufacturing capabilities, competitive pricing, and ability to meet global demand have firmly established it as a key player in the global swab collection kits market, consequently driving the market growth.
Furthermore, the local testing requirements in China have played a crucial role in propelling the expansion of the swab collection kit market. Besides, as a response to the omicron wave, China's National Medical Products Administration (NMPA) granted approval for five COVID-19 antigen kits developed by domestic enterprises for self-testing in 2022.
Some of the key companies operating in the market are: HiMedia Laboratories, Formlabs, Becton, Dickinson and Company, etc.